Ulinastatin in Japan, China, and India
Ulinastatin, a naturally occurring protease modulator generated from human urine, has been used for decades to treat inflammatory disorders like sepsis, acute pancreatitis, and organ failure.
October 9, 2024
by David Orchard-Webb
Even at Same Hospital, Black Patients Face More Complications Than Whites
Black Americans admitted for inpatient hospital care are far more likely than white patients to experience safety-related health complications -- even when both are treated in the same facility, a new report warns.
July 23, 2021
by drugs
Claritas to expand Covid-19 trial to include sepsis treatment
Claritas Pharmaceuticals is set to expand its development programme for R-107 to include the treatment of Covid-19 related sepsis, which is the leading cause of death in infected patients.
April 12, 2021
by pharmaceutical-technology
New Data Demonstrates Nu.Q® is Effective in Monitoring Treatment of Sepsis
VolitionRx Limited, a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, has been working with Swiss-based Santersus AG, a ...
March 17, 2021
by prnasia
Israeli Ministry of Health Authorizes Trial Evaluating Allocetra in Sepsis Patients
Enlivex Therapeutics reported the Israeli Ministry of Health authorized the initiation of a proposed Company-sponsored Phase IIb clinical trial evaluating Allocetra™, in sepsis patients.
November 12, 2020
by americanpharmaceuticalreview
New study assessing antibiotics for COVID-19 sepsis
Researchers from an NIHR-funded study are looking at how to improve the use of antibiotics for patients with COVID-19 who are at risk of developing sepsis and thus organ failure and death.
November 4, 2020
by pharmatimes
Scientists discover 59 repurposing drug candidates for COVID-19
As of this morning – Thursday May 14 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 229,705 with 33,186 deaths.
May 14, 2020
by pharmatimes
India’s CSIR proposes testing of sepsis drug as Covid-19 vaccine
The Council of Scientific and Industrial Research (CSIR) in India has proposed the testing of sepsis treatment drug as a vaccine for Covid-19.
May 8, 2020
by pharmaceutical-technology
Enlivex Initiates Phase II Trial of Allocetra in COVID-19
Will assess Allocetra in combination with therapy in patients with lung dysfunction.
May 8, 2020
by contractpharma
Enlivex Announces Positive Final Safety and Efficacy Data from Allocetra Study
Enlivex Therapeutics announced positive final safety and efficacy data from the Company’s completed Phase Ib clinical trial in patients with severe sepsis.
March 20, 2020
by americanpharmaceuticalreview
Sepsis Causes Far More Deaths Worldwide Than Thought
Sepsis kills more than twice as many people worldwide as once believed, and children in poor regions account for an excessive number of such deaths, researchers say.
January 19, 2020
by drugs
Sepsis Associated With Almost 20 Percent of Global Deaths
From 1990 to 2017, there was a decrease in sepsis incidence and mortality, although considerable regional variation exists, according to a study published online Jan. 16 in The Lancet.
January 17, 2020
by drugs